Ironwood Investment Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-191,170
| Closed | -$2.38M | – | 170 |
|
|
2016
Q4 | $2.38M | Sell |
191,170
-14,840
| -7% | -$179K | 1.74% | 5 |
|
|
2016
Q3 | $2.82M | Sell |
206,010
-87,342
| -30% | -$877K | 2.17% | 2 |
|
|
2016
Q2 | $2.17M | Sell |
293,352
-31,284
| -10% | -$235K | 1.62% | 7 |
|
|
2016
Q1 | $2.07M | Sell |
324,636
-146,880
| -31% | -$823K | 1.36% | 12 |
|
|
2015
Q4 | $2.95M | Sell |
471,516
-108,203
| -19% | -$710K | 1.22% | 23 |
|
|
2015
Q3 | $3.39M | Sell |
579,719
-185,696
| -24% | -$1.43M | 1.24% | 25 |
|
|
2015
Q2 | $6.33M | Sell |
765,415
-245,449
| -24% | -$2.17M | 1.46% | 20 |
|
|
2015
Q1 | $8.33M | Sell |
1,010,864
-8,460
| -0.8% | -$62.5K | 1.54% | 14 |
|
|
2014
Q4 | $7M | Buy |
1,019,324
+351,104
| +53% | +$2.2M | 1.28% | 32 |
|
|
2014
Q3 | $3.61M | Buy |
668,220
+40,740
| +6% | +$238K | 0.65% | 63 |
|
|
2014
Q2 | $4M | Buy |
627,480
+10,093
| +2% | +$69.4K | 0.64% | 65 |
|
|
2014
Q1 | $4.98M | Buy |
617,387
+13,438
| +2% | +$105K | 0.72% | 65 |
|
|
2013
Q4 | $4.12M | Buy |
603,949
+26,754
| +5% | +$144K | 0.57% | 71 |
|
|
2013
Q3 | $10.6M | Buy |
577,195
+11,239
| +2% | +$218K | 1.67% | 12 |
|
|
2013
Q2 | $9.9M | Buy |
+565,956
| New | +$10M | 1.76% | 8 |
|
Other funds holding ARIA
Ironwood Investment Management's ARIA Position: Q1 2017 in Review
Ironwood Investment Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 191,170 shares — an estimated $2.38M sold.
Ironwood Investment Management first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $10.6M in Q3 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.
- Ironwood Investment Management reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
- Ironwood Investment Management sold 191,170 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $2.38M.
- Ironwood Investment Management first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
- Ironwood Investment Management's Ariad Pharmaceuticals Inc position peaked at $10.6M in Q3 2013.
- 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.
Based on Ironwood Investment Management's 13F filing for Q1 2017, filed 16 May 2017.